Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

Novi Review

Compounded-only GLP-1 platform with 50,000+ patients, free 2-day shipping, and no contracts.

Last reviewed July 2026
4 studies cited
Fact-checked 18 July 2026Last updated 15 June 2026From $133 – $349/moEditor Score 4.2 / 5Trustpilot 4.2 · Great (13 reviews)

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Compounded-only GLP-1 platform with 50,000+ patients, free 2-day shipping, and no contracts.

Who it's for: Novi is best for first-time GLP-1 buyers who value brand reassurance over novelty. The published 50,000+ patient count and no-contract structure reduce perceived risk. Free 2-day shipping is a practical differentiator for patients who need consistent supply. Less suited to anyone who wants brand-name Ozempic, Wegovy, or Zepbound — Novi is compounded-only.

Bottom line: Solid mid-pack option with nothing exotic and nothing concerning. The 50,000+ patient count and free 2-day shipping are genuine differentiators at this price point. The compounded-only formulary is the main limitation — if you need brand-name GLP-1 access or want a multi-category clinic, look at Henry Meds or Ivy Rx instead.

Pros
  • Free 2-day shipping included
  • No long-term contracts
  • Established patient volume offers reassurance
Cons
  • Compounded only, no brand-name GLP-1 access
  • No multi-category support

Pros & Cons In Detail

Free 2-day shipping included
Reliable shipping is the most underrated quality signal in telehealth. patients who switch providers usually do so because of refill timing, not price.
No long-term contracts
In practice this is one of the differentiators that pushes Novi's editor score above the category median.
Established patient volume offers reassurance
In practice this is one of the differentiators that pushes Novi's editor score above the category median.
Compounded only, no brand-name GLP-1 access
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
No multi-category support
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Novi Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Novi.

Program / Membership FeeIncluded in monthly plan
Medication Cost (From)From $133 – $349/mo
What This Means For You

Single monthly price covers compounded semaglutide or tirzepatide, provider oversight, and free 2-day shipping. No long-term contracts and no separate membership fee. Pricing is disclosed upfront; dose escalations do not trigger price increases.

Who Novi Is For

Novi is best for first-time GLP-1 buyers who value brand reassurance over novelty. The published 50,000+ patient count and no-contract structure reduce perceived risk. Free 2-day shipping is a practical differentiator for patients who need consistent supply. Less suited to anyone who wants brand-name Ozempic, Wegovy, or Zepbound — Novi is compounded-only.

How Novi Markets Itself

First-time GLP-1 buyers who want a no-contract program with established patient volume.

Signature Programs

  • ›Compounded semaglutide
  • ›Compounded tirzepatide
  • ›Free 2-day shipping

Medication Formulary

Full Formulary
compounded semaglutidecompounded tirzepatide

The Bottom Line

Solid mid-pack option with nothing exotic and nothing concerning. The 50,000+ patient count and free 2-day shipping are genuine differentiators at this price point. The compounded-only formulary is the main limitation — if you need brand-name GLP-1 access or want a multi-category clinic, look at Henry Meds or Ivy Rx instead.

With an editor score of 4.2 / 5 across cost, experience, and trust, Novi is one of the strong mid-tier options in the glp-1 weight loss category we cover.

See how Novi compares in our full glp-1 weight loss rankings, or read the Best Compounded GLP-1 Telehealth Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
  4. FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

Alternatives To Novi

§ Continue Reading